| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |